Your browser doesn't support javascript.
loading
Distinct Dynamics of Migratory Response to PD-1 and CTLA-4 Blockade Reveals New Mechanistic Insights for Potential T-Cell Reinvigoration following Immune Checkpoint Blockade.
Safaeifard, Fateme; Goliaei, Bahram; Aref, Amir R; Foroughmand-Araabi, Mohammad-Hadi; Goliaei, Sama; Lorch, Jochen; Jenkins, Russell W; Barbie, David A; Shariatpanahi, Seyed Peyman; Rüegg, Curzio.
Afiliación
  • Safaeifard F; Laboratory of Biophysics and Molecular Biology, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran 1417614411, Iran.
  • Goliaei B; Laboratory of Biophysics and Molecular Biology, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran 1417614411, Iran.
  • Aref AR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Foroughmand-Araabi MH; Xsphera Biosciences Inc., Boston, MA 02210, USA.
  • Goliaei S; Department of Mathematical Sciences, Sharif University of Technology, Tehran P.O. Box 11155-9415, Iran.
  • Lorch J; Faculty of New Sciences & Technologies, University of Tehran, Tehran 1439957131, Iran.
  • Jenkins RW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Barbie DA; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60611, USA.
  • Shariatpanahi SP; MassGeneral Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
  • Rüegg C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Cells ; 11(22)2022 11 08.
Article en En | MEDLINE | ID: mdl-36428963

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cells Año: 2022 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cells Año: 2022 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Suiza